Luigi Fattore

Rome, Italy

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 37 publications

Emerging role of microRNAs as modulators of the tumor immune microenvironment.

Emerging role of microRNAs as modulators of the tumor immune microenvironment.

Journal: Journal for immunotherapy of cancer
Published: June 03, 2026

miRNA-driven cancer cell plasticity, tolerance and therapy resistance: lessons from melanoma.

miRNA-driven cancer cell plasticity, tolerance and therapy resistance: lessons from melanoma.

Journal: Molecular cancer
Published: November 19, 2025

PROTAC-mediated degradation of Bcl-xL potentiates target therapy in preclinical melanoma models.

PROTAC-mediated degradation of Bcl-xL potentiates target therapy in preclinical melanoma models.

Journal: Journal of experimental & clinical cancer research : CR
Published: August 25, 2025

Development of an innovative duplex digital PCR assay for circulating MiRNA ratio quantification in metastatic melanoma.

Development of an innovative duplex digital PCR assay for circulating MiRNA ratio quantification in metastatic melanoma.

Journal: Journal of translational medicine
Published: June 24, 2025

The Society for Immunotherapy of Cancer Perspective on Liquid Biopsy- and Radiomics-Based Technologies for Immuno-oncology Biomarker Discovery and Application.

The Society for Immunotherapy of Cancer Perspective on Liquid Biopsy- and Radiomics-Based Technologies for Immuno-oncology Biomarker Discovery and Application.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: November 18, 2024

The Society for Immunotherapy of Cancer Perspective on Tissue-Based Technologies for Immuno-Oncology Biomarker Discovery and Application.

The Society for Immunotherapy of Cancer Perspective on Tissue-Based Technologies for Immuno-Oncology Biomarker Discovery and Application.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: July 31, 2024

The MITF/mir-579-3p regulatory axis dictates BRAF-mutated melanoma cell fate in response to MAPK inhibitors.

The MITF/mir-579-3p regulatory axis dictates BRAF-mutated melanoma cell fate in response to MAPK inhibitors.

Journal: Cell death & disease
Published: September 07, 2023

Upregulated expression of miR-4443 and miR-4488 in drug resistant melanomas promotes migratory and invasive phenotypes through downregulation of intermediate filament nestin.

Upregulated expression of miR-4443 and miR-4488 in drug resistant melanomas promotes migratory and invasive phenotypes through downregulation of intermediate filament nestin.

Journal: Journal of experimental & clinical cancer research : CR
Published: August 21, 2023

The new world of RNA diagnostics and therapeutics.

The new world of RNA diagnostics and therapeutics.

Journal: Journal of experimental & clinical cancer research : CR
Published: June 16, 2023

Genome-wide profiling of patient-derived glioblastoma stem-like cells reveals recurrent genetic and transcriptomic signatures associated with brain tumors.

Genome-wide profiling of patient-derived glioblastoma stem-like cells reveals recurrent genetic and transcriptomic signatures associated with brain tumors.

Journal: Journal of neuro-oncology
Published: January 31, 2023

Identification of a miRNA-based non-invasive predictive biomarker of response to target therapy in BRAF-mutant melanoma.

Identification of a miRNA-based non-invasive predictive biomarker of response to target therapy in BRAF-mutant melanoma.

Journal: Theranostics
Published: August 04, 2022

Oncosuppressive miRNAs loaded in lipid nanoparticles potentiate targeted therapies in BRAF-mutant melanoma by inhibiting core escape pathways of resistance.

Oncosuppressive miRNAs loaded in lipid nanoparticles potentiate targeted therapies in BRAF-mutant melanoma by inhibiting core escape pathways of resistance.

Journal: Oncogene
Published: June 11, 2022
Showing 1-12 of 37

Last Updated: 09/26/2026